Table III.
Differentially expressed nasal mucosa miRNAs in allergic mice post-treatment with ipratropium bromide.
| Expression level (TPM) | log2 (Fold change)a | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| miRNA | A | B | C | D | E | A/C | B/C | D/C | E/C |
| mmu-miR-124-3p | 293.5 | 377.3 | 4.4 | 101.4 | 14.4 | 5.6 | 5.9 | 4.5 | 1.2 |
| mmu-miR-124-5p | 26.8 | 32.6 | 0.3 | 10 | 1.2 | 5.9 | 6.1 | 4.9 | 1.3 |
| mmu-miR-133a-3p | 755.3 | 964.6 | 16.3 | 72.6 | 1,272.6 | 5.1 | 5.4 | 2.2 | 5.8 |
| mmu-miR-133a-5p | 48.9 | 55.9 | 0.7 | 2.4 | 60.1 | 5.7 | 5.8 | 1.8 | 5.9 |
| mmu-miR-133b-3p | 46.5 | 47.9 | 1.7 | 5.3 | 74.9 | 4.4 | 4.3 | 1.7 | 4.9 |
| mmu-miR-138-5p | 69 | 93.6 | 6.1 | 23.8 | 22.8 | 3.1 | 3.4 | 2 | 1.4 |
| mmu-miR-181a-5p | 2,114.3 | 2,962.1 | 967.2 | 1,279.7 | 2,957.1 | 0.7 | 1.1 | 0.4 | 1.1 |
| mmu-miR-181b-5p | 364.9 | 453.5 | 139.3 | 223.3 | 493.2 | 1 | 1.2 | 0.7 | 1.3 |
| mmu-miR-181c-5p | 28.7 | 32.2 | 4.1 | 4.4 | 35.7 | 2.4 | 2.5 | 0.1 | 2.6 |
| mmu-miR-181d-5p | 102.7 | 87.2 | 33.2 | 45.2 | 95 | 1.2 | 0.9 | 0.5 | 1 |
| mmu-miR-1a-3p | 18,773.7 | 21,540.8 | 728.6 | 4,349.9 | 21,603.1 | 4.3 | 4.4 | 2.6 | 4.4 |
| mmu-miR-1b-5p | 18,757.4 | 21,523.9 | 727.9 | 4,348.7 | 21,586.7 | 4.3 | 4.4 | 2.6 | 4.4 |
| mmu-miR-206-3p | 79.1 | 99.1 | 2.4 | 19.7 | 165.9 | 4.6 | 4.9 | 3.1 | 5.6 |
| mmu-miR-3071-3p | 39.2 | 83.8 | 6.1 | 24.4 | 41.7 | 2.3 | 3.3 | 2 | 2.2 |
| mmu-miR-3071-5p | 178 | 160.1 | 15.2 | 74.6 | 82.5 | 3.1 | 2.9 | 2.3 | 1.9 |
| mmu-miR-378a-3p | 3,206.9 | 4,143.5 | 6,531.4 | 4,011.7 | 3,798.9 | −1.5 | −1.2 | −0.7 | −1.3 |
| mmu-miR-378c | 529.6 | 558.1 | 900.1 | 408.4 | 618.3 | −1.2 | −1.2 | −1.1 | −1.1 |
| mmu-miR-384-3p | 14.3 | 17.8 | 0.3 | 9.1 | 2.4 | 5 | 5.2 | 4.8 | 2.3 |
| mmu-miR-384-5p | 12.8 | 12.7 | 0.3 | 6.2 | 1.2 | 4.8 | 4.7 | 4.2 | 1.3 |
a
Fold change, TPM of group D (or E or A or B)/TPM of group C. TPM, transcripts per million (evaluates the relative expression level of differentially expressed miRNAs); miRNA, micro RNA.